Combining previous researches and our results, we speculated SLC25A4, SLC25A5, SLC25A9, and SLC2512 might participate in metabolic reprogramming and cancer initiation and development via these oncogenic and metabolic pathways. The gene discussed is SLC25A4; the disease is cancer.